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ABSTRACT 
Objective: To develop and validate stability indicating method for the analysis of Memantine HCl and Donepezil HCl. 
Methods: The chromatographic separation was performed on Hypersil BDS (4.6 x 150 mm, 5µ) using Sodium dihydrogen ortho phosphate: 
Acetonitrile (30:70v/v) at a flow rate of 1 ml/min and detection of both the eluents was carried out by UV Detector. 
Results: The Retention time of Memantine HCl and Donepezil HCl were found to be 2.833 min. and 4.777 min respectively. Method was found to be 
linear over the range of 40-120μg/ml for Memantine HCl and 20-60μg/ml for Donepezil HCl. Percentage recovery of Memantine HCl and Donepezil 
HCl was found to be 99.62% and 99.45% respectively. The percentage purity thus found is 98.5% and 98.6% for Memantine HCl and Donepezil HCl. 
The Limit of Detection of Memantine HCl and Donepezil HCl is 3.69 µg/ml and 2.72 µg/ml. and Limit of Quantification of Memantine HCl and 
Donepezil HCl is 11.13 µg/ml and 8.25 µg/ml respectively. In the stress degradation studies, it was found that Memantine HCl and Donepezil HCl 
showed no degradation in acid (0.1M HCl), base (0.1M NaOH), peroxide, heat and sunlight.  
Conclusion: A new sensitive, simple, and stability indicating high performance layer chromatographic (HPLC) method has been developed and 
validated for determination of Memantine HCl and Donepezil HCl. The proposed method can be used for routine determination of Memantine HCl 
and Donepezil HCl stability. 
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INTRODUCTION 
Memantine hydrochloride chemically is 1-amino-3,5-dimethyl-
adamantane hydrochloride. It is an anti-Alzheimer’s drug and exerts 
its action through uncompetitive N-Methyl D-Aspartate (NMDA) 
receptor antagonism, binding preferentially to the NMDA receptor-
operated cation channels. Donepezil hydrochloride is chemically (±)-2, 
3-dihydro-5, 6-dimethoxy-2-[1-(phenylmethyl)-4-piperidinyl] methyl]-
1H-inden-1-onehydrochloride, a piperidine derivative that is a centrally 
active, reversible inhibitor of acetyl cholinesterase.  
Its proposed mechanism of action involves the reversible inhibition of 
cholinesterase, which prevents the hydrolysis of acetylcholine, and 
leads to an increased concentration of acetylcholine at cholinergic 
synapses.  
The literature survey revealed that a number of methods being 
reported for the estimation of Memantine HCl [11-20] and Donepezil 
HCl [21-32] individually but only two methods have been reported 
on the combination [33,34]. The present work involves a simple and 
reliable stability indicating RP-HPLC method for the estimation of 




Fig. 1: Chemical structure of Memantine HCl 
 
 
Fig. 2: Chemical structure of Donepezil HCl 
 
MATERIALS AND METHODS 
Instrumentation 
HPLC (Agilent-1220 infinity series), pump–2690, UV Detector 
(Nicolet evolution 100), EZ Chrome software, Sonicator & degasser 
(PCI Analyte), pH meter (Lab India), Hot air oven (Lab India), Nylon 
filter. 
Chemicals and reagents 
Memantine HCl and Donepezil Hydrochloride were obtained from 
the Dr. Reddy Labs, Hyderabad, India, as a gift sample. Combined 
dose tablet formulation, Donamem 10 (Sun Pharmaceuticals Ltd) 
containing Memantine HCl 10 mg and Donepezil HCl 5 mg was 
obtained from local pharmacy store. Sodium dihydrogen phosphate, 
Ortho Phosphoric acid, Acetonitrile, Triethyl Amine are obtained 
from commercial sources (S. D. fine chemicals) and all the reagents 
are of Analytical grade. 
Methodology 
Preparation of 0.02M Sodium dihydrogen phosphate 
3.12 gm of Sodium dihydrogen phosphate (NaH2PO4) was accurately 
weighed and dissolved in 1000 ml water. This prepared buffer was 
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filtered through the nylon membrane filter having a pore size of 0.45 
µm and degassed with the help of a sonicator. 
Standard solution of Memantine HCl 
Standard stock solution of Memantine HCl was prepared by 
dissolving 10 mg of drug in 0.02M Sodium dihydrogen phosphate 
solution to get concentration of 400 µg/ml. 
Standard stock solution of Donepezil HCl 
Standard stock solution of Donepezil HCl was prepared by dissolving 
10 mg of drug in 0.02M Sodium dihydrogen phosphate solution to 
get concentration of 200 µg/ml. 
Selection of analytical wavelength 
The standard solution of mixed solution of Memantine HCl & 
Donepezil HCl in methanol was scanned over wavelength range 200 
to 400 nm by using UV-Visible spectrophotometer. Wavelength 271 
nm was selected for analysis where the combined drug solution 
showed higher absorbance.  
Chromatographic conditions 
Chromatographic separation was carried out on Hypersil BDS (4.6 x 
150 mm, 5µ) using mobile phase Sodium dihydrogen ortho 
phosphate: Acetonitrile (30:70v/v) at a flow rate 1 ml/min for 6 
min. Detection of both the eluents was carried out by UV Detector. 
 
Fig. 3: UV spectrum of mixed drug solution between 200-400 nm 
 
Assay 
To carry out the assay of the method, %purity was calculated. 5 
injections of standard and sample (formulation) having 100% 
concentration (80µg/ml of Memantine HCl and 40µg/ml of 
Donepezil HCl) of drugs were injected simultaneously and the peak 
area were recorded. 
 
 
Fig. 4: Chromatogram showing retention time of Memantine HCl and Donepezil HCl 
 
 Memantine Donepezil 
 Standard area Sample area Standard area Sample area 
Injection-1 768.820 761.374 546.817 538.641 
Injection-2 767.589 767.612 543.171 541.972 
Injection-3 764.499 764.499 537.068 537.068 
Injection-4 767.339 767.339 542.561 542.561 
Injection-5 761.946 761.946 546.817 546.817 
Average area 766.0386 764.554 543.2868 541.4118 
Tablet average weight 195.6 195.6 
Standard weight 100 50 
Equivalent weight 195.6 195.6 
Label amount 10 mg 5 mg 
std. purity 99.8 99.8 
Amount found in mg 9.85 4.93 
Assay(%purity) 98.5 98.6 
 
Validation 
Working standard solution of Memantine HCl and Donepezil HCl 
20 tablets (each tablet contains 5 mg of Donepezil HCl and 10 mg of 
Memantine HCl) were weighed and taken into a mortar and crushed to 
fine powder and mixed uniformly. Tablet stock solution was prepared 
by dissolving powder weight equivalent to 50 mg of Donepezil HCl and 
100 mg of Memantine HCl in sufficient mobile phase. The solution was 
filtered through the nylon membrane filter having a pore size of 0.45 
µm and degassed with the help of a sonicator. 
Specificity 
The specificity of the method was ascertained by analyzing standard 
drug and sample (dosage form). The specificity of the method was 
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confirmed by comparing the peaks of the sample and standard 
injected having the same concentration of drugs. 
Linearity 
Appropriate volumes were injected from standard stock solution 
containing 40-120 µg/ml of Memantine HCl and 20-60μg/ml of 
Donepezil HCl respectively. Each standard was analyzed in five 
replicates, and peak area was noted. The relationship between peak 
area and concentration was established by the simple regression 
equation method. 
Accuracy 
To check accuracy in the method, recovery studies were carried out 
at three different levels 75%, 100%, 125%. 0.8 ml of working 
solution was pipette out and dissolved in 10 ml mobile phase which 
gave a 100% solution.  
Similarly 0.6 ml and 1.0 ml of working solution were pipette out and 
dissolved in 10 ml mobile phase to give 75% and 125% solutions 
respectively. The solutions were prepared in triplicates and the 








Fig. 5: (a) (b) (c) (d) (e)–Chromatograms of Linearity 
Amena et al. 




Fig. 6: Calibration curve of memantine HCl 
 
 
Fig. 7: Calibration curve of Donepezil HCl 
 
Table 1: Linearity data for Memantine HCl and Donepezil HCl 
Regression Analysis Memantine HCl Donepezil HCl 
Regression equation y = 9.6796x-0.323 y = 14.591x-28.917 
Correlation co-efficient 0.9991 0.999 
Slope 9.6796 14.591 
Intercept 0.323 28.917 
 
Table 2: Results for method precision of Memantine HCl and Donepezil HCl 
 Memantine HCl Donepezil HCl 
Avg. Rt 2.7500 4.6393 
Standard Deviation 0.0079 0.0113 
%RSD 0.29 0.24 
*Average of 6 injections 
 
Table 3: Recovery data 
Conc. Amt of sample (μg/ml) Amt. found (μg/ml) % Recovery 
 Memantine HCl Donepezil HCl Memantine HCl Donepezil HCl Memantine HCl Donepezil HCl 
75% 60 30 59.91 29.91 99.84 99.71 
100% 80 40 79.32 39.78 99.15 99.46 
125% 100 50 99.89 49.59 99.89 99.18 
* Average of 3 injections each 
 
Precision 
It was assessed by injecting six injections of a homogenous sample 
containing 80µg/ml of Memantine HCl and 40µg/ml of Donepezil 
HCl and % RSD was calculated. 
Robustness 
The robustness of the method was studied by small but deliberate 
variations from the optimized conditions in wavelength (±2 nm) and 
in Flow rate (±0.2 ml/min). One factor at a time was changed at a 
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concentration level of 80µg/ml of Memantine HCl and 40µg/ml of 
Donepezil HCl and the peak area obtained with each solution was 
measured and % R. S. D was calculated. 
Ruggedness 
Different Analysts performed the experiment keeping the other 
parameters unchanged and in parallel, the chromatographic profile 
was observed and recorded. 
Limit of Detection and Limit of Quantification (LOD & LOQ) 
The LOD and LOQ were estimated from the calibration curve. The 
LOD may be calculated as LOD = 3.3 × (SD/Slope) 
The LOQ may be calculated as LOQ = 10 × (SD/Slope) 
Where, SD = Standard deviation of the Y-intercept of the calibration 
curve. 
Slope = Mean slope of the calibration curve. 
 
Table 4: Robustness data 
Condition Memantine HCl (Tailing factor) Donepezil HCl (Tailing factor) 
Wavelength 269 nm 1.758 1.537 
273 nm 1.727 1.585 
Flow rate 0.8 ml/min 1.773 
1.714 
1.630 
1.556 1.2 ml/min 
 
Table 5: Ruggedness data 
Memantine HCl %Assay Donepezil HCl %Assay 
Analyst1 99.36  Analyst1 99.67 
Analyst2 98.67 Analyst2 98.45 
%RSD 0.4% %RSD 0.8% 
 
Stress degradation studies 
Stress degradation studies were carried under a condition of 
acid/base/neutral hydrolysis, oxidation, dry heat and photolysis. For 
each study, samples were prepared, the blank subjected to stress in 
the same manner for the drug solution, working standard solution of 
Memantine HCl & Donepezil HCl subjected to stress degradation. Dry 
heat and photolytic degradation were carried out in a solid state.  
Acid degradation  
One ml working standard solution was mixed with one ml of 0.1 N 
HCL and the solution was kept in the water bath at 60 °C for 1 hr. 
Then the solution was allowed to cool at room temperature. The 
solution was filtered using 0.45-micron syringe filter and sonicated 
for 5 min and diluted to 100 ml with the mobile phase. Further 
dilutions were made to prepare 40μg/ml of Donepezil HCl and 
80μg/ml of Memantine HCl by adding 0.8 ml of the above solution to 
10 ml of the mobile phase. 
Base degradation 
One ml working standard solution was mixed with one ml of 0.1N 
NaOH and the solution was kept in the water bath at 60 °C for 1 hr. 
Then the solution was allowed to cool at room temperature. The 
solution was filtered using 0.45-micron syringe filter and sonicated 
for 5 min and diluted to 100 ml with the mobile phase. Further 
dilutions were made to prepare 40μg/ml of Donepezil HCl and 
80μg/ml of Memantine HCl by adding 0.8 ml of the above solution to 
10 ml of mobile phase. 
Oxidative degradation 
One ml working standard solution was mixed with one ml of 1.0% 
H2O2 and the solution was kept in water bath at 60 °C for 1 hr. Then 
the solution was allowed to cool at room temperature. The solution 
was filtered using 0.45-micron syringe filter and sonicated for 5 min 
and diluted to 100 ml with mobile phase. Further dilutions were 
made to prepare 40μg/ml of Donepezil HCl and 80μg/ml of 
Memantine HCl by adding 0.8 ml of the above solution to 10 ml of 
mobile phase. 
Dry Heat degradation 
Sample was exposed at 105 °C in an oven for 1 hour. 
Sample was withdrawn, dissolved in mobile phase and diluted to get 
40μg/ml of Donepezil HCl and 80μg/ml of Memantine HCl by adding 
0.8 ml of the above solution to 10 ml of mobile phase. 
Photolytic degradation  
Sample was exposed in sunlight for 24 h. 
Sample was withdrawn, dissolved in mobile phase and diluted to get 
40μg/ml of Donepezil HCl and 80μg/ml of Memantine HCl by adding 
0.8 ml of the above solution to 10 ml of mobile phase. 
 
Table 6: Results for Degradation studies of Memantine HCl 
Conditions Sample weight(mg) Peak area % claim % Degradation 
Sample Control 187.6 768.82 98.49 - 
Acid Degradation 189.98 767.589 98.38 0.19 
Alkali Degradation 189.56 756.523 97.19 1.3 
Thermal Degradation 188.97 757.337 97.59 0.9 
Peroxide Degradation 189.64 768.820 97.64 0.85 
UV Degradation 189.32 763.374 98.19 0.3 
 
Table 7: Results for Degradation studies of Donepezil HCl 
Conditions Sample weight(mg) Peak Area % claim % Degradation 
Sample Control 187.6 548.815 98.63 - 
Acid Degradation 187.29 543.171 98.93 1.7 
Alkali Degradation 187.23 523.198 95.67 2.96 
Thermal Degradation 189.32 546 96.74 1.89 
Peroxide Degradation 186.97 546.817 97.77 0.86 
UV Degradation 186.89 533.408 97.36 1.27 
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RESULTS AND DISCUSSION 
Optimization of mobile phase 
Method development for Memantine HCl & Donepezil HCl was started 
with the development of chromatograms using neat solvents and 
combinations of Methanol, Sodium dihydrogen phosphate, Acetonitrile 
in different ratios. Sodium dihydrogen phosphate: Acetonitrile in the 
ratio of (30:70 v/v) was selected as the mobile phase for Memantine HCl 
& Donepezil HCl, which resulted in acceptable peak parameters. The 
retention time of Memantine HCl and Donepezil HCl was found to be 
2.833 min. and 4.777 min respectively. 
Method validation 
The method validation results were satisfactory as per ICH Q2R1 
guidelines. The peak areas were found to be linear over the 
concentration range 40-120μg/ml for Memantine HCl and 20-
60μg/ml for Donepezil HCl with a correlation co-efficient of 
0.9991 and 0.999 respectively. Method precision was less than 
2%. Percent recovery in accuracy study was within the limit of 98 
to 102%. The percentage purity thus found is 98.8% and 98.6% for 
Memantine HCl and Donepezil HCl. Thus, the optimized HPLC 
method for Memantine HCl & Donepezil HCl is based on use of 
simple ternary mixture of organic solvents. The method is found to 
be sensitive with LOD 3.69 µg/ml and 2.72 µg/ml and LOQ of 
Memantine HCl and Donepezil HCl is 11.13 µg/ml and 8.25 µg/ml 
respectively.  
All the validated parameters are given in table 8. 
Stress degradation 
Drug was subjected to various forced degradation conditions. The 
conditions of stress were optimized with respect to the strength of 
the reagent and exposure period so as to achieve degradation in the 
range of 1 to 15%. There was no peak of degradation found in any of 
the degradation process. 
Summary of stress degradation results is given in table 6 and 7. 
The advantage of this method from the previous methods proposed 
for the drugs is that it gives a lesser retention time and also the 
detection method used is economical and easily available. 
  
Table 8: Summary of the validation parameters of proposed method 
S. No. Parameter Memantine HCl Donepezil HCl 
01 Linearity Range 40-120µg/ml 20-60 µg/ml 
02 Regression equation y = 9.6796x-0.323 y = 14.591x-28.917 
03 Correlation co-efficient 0.9991 0.999 
04 Specificity No interference at the RT No interference at the RT 
05 Precision(% RSD) 0.29 0.24 
06 Accuracy (% recovery) 99.62% 99.45% 
07 Assay(%Purity) 98.8% 98.6% 
08 Robustness Tailing<2 Tailing<2 
09 Ruggedness Tailing<2 Tailing<2 
10 Limit of Detection 3.69µg/ml 2.72µg/ml 
11 Limit of Quantification 11.13µg/ml 8.25µg/ml 
 
CONCLUSION 
The developed RP-HPLC method provides simple, specific, precise, 
accurate, economical and reproducible quantitative analysis for 
simultaneous determination of Memantine HCl and Donepezil HCl in 
combined tablet dosage form. The method was validated as per ICH 
guidelines in terms of linearity, accuracy, precision, limits of detection 
(LOD) and quantification (LOQ). The method can be used for routine 
analysis of Memantine HCl and Donepezil HCl in combined dosage form. 
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